0001104659-22-072185.txt : 20220617
0001104659-22-072185.hdr.sgml : 20220617
20220617082706
ACCESSION NUMBER: 0001104659-22-072185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PAREKH RAJESH B
CENTRAL INDEX KEY: 0001429930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31326
FILM NUMBER: 221022461
MAIL ADDRESS:
STREET 1: ALCHESTER HOUSE, LANGFORD LANE
STREET 2: NORTH WENDLEBURY
CITY: BICHESTER
STATE: X0
ZIP: OX6 ONS
FORMER NAME:
FORMER CONFORMED NAME: PAREKH RAJESH R
DATE OF NAME CHANGE: 20080317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eloxx Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001035354
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 841368850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY
STREET 2: SUITE 130
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 781-577-5300
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY
STREET 2: SUITE 130
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Sevion Therapeutics, Inc.
DATE OF NAME CHANGE: 20140930
FORMER COMPANY:
FORMER CONFORMED NAME: SENESCO TECHNOLOGIES INC
DATE OF NAME CHANGE: 19991006
FORMER COMPANY:
FORMER CONFORMED NAME: NAVA LEISURE USA INC
DATE OF NAME CHANGE: 19970310
4
1
tm2218714-4_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-06-15
0
0001035354
Eloxx Pharmaceuticals, Inc.
ELOX
0001429930
PAREKH RAJESH B
C/O ELOXX PHARMACEUTICALS, INC
480 ARSENAL WAY, SUITE 130
WATERTOWN
MA
02472
1
0
0
0
Stock Options (Right to Buy)
0.26
2022-06-15
4
A
0
20000
0
A
2032-06-15
Common Stock
20000
20000
D
The stock option vests as to 50% of the underlying shares on June 15, 2023 and the remainder in twelve (12) equal monthly installments thereafter.
The Reporting Person will assign the economic interests of this grant to Advent Life Sciences LLP. The Reporting Person is a general partner of Advent Life Sciences LLP.
/s/ Sumit Aggarwal, Attorney-in-Fact for Rajesh B. Parekh
2022-06-16